🔥🐔 BizChicken 🐔🔥
Companies Similar to Ventyx Biosciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Biogen Inc.
TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, FAMPYRA, SPINRAZA, FUMADERM, BENEPALI, ADUHELM, IMRALDI, FLIXABI, RITUXAN, RITUXAN HYCELA, GAZYVA, OCREVUS
Biogen Inc. focuses on discovering, developing, manufacturing, and delivering therapies for neurological and neurodegenerative diseases, including multiple sclerosis, spinal muscular atrophy, plaque psoriasis, Alzheimer's disease, and various cancers and autoimmune conditions.
About | About | Vision/Values | Leadership | Foundation | Contact | Careers | Careers | Careers | Careers | Careers | About | About | Careers | Careers | Careers | Careers | Benefits | Careers | Careers | Careers | Careers | About | About | About | About
Symbol: BIIB
Recent Price: $150.19
Industry: Drug Manufacturers - General
CEO: Mr. Christopher A. Viehbacher
Sector: Healthcare
Employees: 7570
Address: 225 Binney Street, Cambridge, MA 02142
Phone: 617 679 2000
Leadership
- Christopher A. Viehbacher, President and Chief Executive Officer
- Susan H. Alexander, Chief Legal Officer
- Ginger Gregory, Ph.D., Chief Human Resources Officer
- Jane Grogan, Ph.D., Head of Research
- Rachid Izzar, Head of Global Product Strategy & Commercialization
- Adam Keeney, Head of Corporate Development
- Michael McDonnell, Chief Financial Officer
- Nicole Murphy, Head of Pharmaceutical Operations and Technology
- Priya Singhal, M.D., M.P.H., Head of Development and Interim Chief Medical Officer
- Alisha Alaimo, President, Head of North America
- Stephen Amato, Head of Investor Relations
- Natacha Gassenbach, Head of Corporate Affairs, Chief Communications Officer
- Fraser Hall, President, Head of Intercontinental Region
- Wolfram Schmidt, President, Head of Europe
- Kendra Thomas, Head of Global Workforce Diversity, Equity & Inclusion (DE&I)
- Caroline Dorsa, Chair of the Board
- Maria C. Freire, Ph.D., Director
- William A. Hawkins, Director
- Susan Langer, Director
- Jesus B. Mantas, Director
- Lloyd B. Minor, M.D., Director
- Monish Patolawala, Director
- Eric K. Rowinsky, M.D., Director
- Stephen A. Sherwin, M.D., Director
Last updated: 2024-12-31
Anixa Biosciences, Inc.
Chimeric Endocrine Receptor T-cell Technology, Anti-Viral Drug Candidates, Vaccines
Anixa Biosciences, Inc. is a biotechnology company focused on developing therapies and vaccines for oncology and infectious diseases, including novel CAR-T technologies for ovarian cancer and vaccines for breast and ovarian cancer.
Symbol: ANIX
Recent Price: $2.50
Industry: Biotechnology
CEO: Dr. Amit Kumar Ph.D.
Sector: Healthcare
Employees: 4
Address: 3150 Almaden Expressway, San Jose, CA 95118
Phone: 408 708 9808
Last updated: 2024-12-31
ImmunityBio, Inc.
Therapies and Vaccines
Immunity Bio, Inc. is a clinical-stage biotechnology company developing therapies and vaccines to treat cancers and infectious diseases, with a focus on immunotherapy and cell therapy platforms. The company collaborates with several institutes and has multiple therapeutic agents in clinical trials.
Symbol: IBRX
Recent Price: $2.68
Industry: Biotechnology
CEO: Mr. Richard Gerald Adcock
Sector: Healthcare
Employees: 622
Address: 3530 John Hopkins Court, San Diego, CA 92121
Phone: 858 633 0300
Last updated: 2024-12-31
Inhibrx Biosciences, Inc.
Therapeutic Candidates (INBRX-109, INBRX-106)
Inhibrx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops biologic therapeutics for life-threatening conditions, with therapeutic candidates in phase 2 clinical trials targeting various cancers.
Symbol: INBX
Recent Price: $15.14
Industry: Biotechnology
CEO: Mr. Mark Paul Lappe
Sector: Healthcare
Employees: 166
Address: 11025 North Torrey Pines Road, La Jolla, CA 92037
Phone: 858-795-4220
Last updated: 2024-12-31
Novavax, Inc.
NVX-Co V2373
Novavax, Inc. is a biotechnology company focused on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases. Their vaccine candidates include NVX-Co V2373, Nano Flu, and Res Vax. The company operates collaboratively with Takeda Pharmaceutical Company Limited on COVID-19 vaccine development.
Contact | Careers | Careers | Careers | Careers | About | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | Jobs | About | About | About | About | About | About
Symbol: NVAX
Recent Price: $7.93
Industry: Biotechnology
CEO: Mr. John Charles Jacobs M.B.A.
Sector: Healthcare
Employees: 1543
Address: 21 Firstfield Road, Gaithersburg, MD 20878
Phone: 240 268 2000
Last updated: 2024-12-31
Revelation Biosciences, Inc.
REVTx-99b
Revelation Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing immune system therapeutics and diagnostics, including products for chronic nasal congestion, allergic rhinitis, chronic organ disease, and viral infections.
Symbol: REVB
Recent Price: $0.39
Industry: Biotechnology
CEO: Mr. James M. Rolke
Sector: Healthcare
Employees: 9
Address: 4660 La Jolla Village Drive, San Diego, CA 92122
Phone: 650-800-3717
Last updated: 2024-12-31
Vaccinex, Inc.
pepinemab
Vaccinex, Inc., a clinical-stage biotechnology company, focuses on developing targeted biotherapeutics for cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate, pepinemab, is in clinical trials for multiple serious conditions.
Contact | Contact | Careers | About | Careers | About | About | About | About | About | News | Events | About | About | ESG | About | About | About | About | About
Symbol: VCNX
Recent Price: $1.11
Industry: Biotechnology
CEO: Dr. Maurice Zauderer Ph.D.
Sector: Healthcare
Employees: 37
Address: 1895 Mount Hope Avenue, Rochester, NY 14620
Phone: 585 271 2700
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Avalo Therapeutics, Inc.
AVTX-002, AVTX-007, AVTX-801
Avalo Therapeutics, Inc. is a clinical-stage precision medicine company focused on discovering, developing, and commercializing targeted therapeutics for patients with unmet clinical needs in immunology, immuno-oncology, and rare genetic diseases.
Symbol: AVTX
Recent Price: $7.80
Industry: Biotechnology
CEO: Dr. Garry A. Neil M.D.
Sector: Healthcare
Employees: 19
Address: 540 Gaither Road, Rockville, MD 20850
Phone: 410 522 8707
Leadership
- Garry A. Neil, MD, Chairman of the Board and Chief Executive Officer
- Mittie Doyle, MD, FACR, Chief Medical Officer
- Chris Sullivan, Chief Financial Officer
- Paul Varki, Chief Legal Officer
- Lisa Hegg PhD, Senior Vice President, Program Management and Corporate Infrastructure and Clinical Operations
- Colleen Matkowski, Senior Vice President, Global Regulatory Affairs and Quality Assurance
- Dino C. Miano, PhD, Senior Vice President, CMC and Technical Operations
- June Almenoff, MD, PhD, President and Chief Medical Officer
- Mitchell Chan, Chief Financial Officer
- Jonathan Goldman, MD, CEO
- Aaron Kantoff, Managing Partner
- Gilla Kaplan, PhD, Independent Director
- Samantha Truex, CEO
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
Vaxcyte, Inc.
VAX-24
Vaxcyte, Inc. is a clinical-stage biotechnology company developing novel protein vaccines for preventing or treating bacterial infectious diseases. Key products include the VAX-24 pneumococcal conjugate vaccine and other candidates targeting antibiotic resistance and periodontitis.
Symbol: PCVX
Recent Price: $81.99
Industry: Biotechnology
CEO: Mr. Grant E. Pickering M.B.A.
Sector: Healthcare
Employees: 254
Address: 825 Industrial Road, San Carlos, CA 94070
Phone: 650 837 0111
Last updated: 2024-12-31
Vincerx Pharma, Inc.
VIP152
Vincerx Pharma, Inc. is a clinical-stage biopharmaceutical company focused on researching and developing therapies to address unmet medical needs for cancer treatment in the United States. Their lead product candidate, VIP152, is a cyclin-dependent kinase-9 inhibitor for advanced cancer.
Symbol: VINC
Recent Price: $0.33
Industry: Biotechnology
CEO: Dr. Ahmed M. Hamdy M.D.
Sector: Healthcare
Employees: 42
Address: 260 Sheridan Avenue, Palo Alto, CA 94306
Phone: 650 800 6676
Last updated: 2024-12-31
Vaxxinity, Inc.
UB-311, UB-312, UB-313, UB-612
Vaxxinity, Inc. is a biotechnology company focused on developing product candidates for neurology and coronavirus-related treatments, including Alzheimer's, Parkinson's disease, migraines, and SARS-CoV-2.
Symbol: VAXX
Recent Price: $0.00
Industry: Biotechnology
CEO: Ms. Mei Mei Hu J.D.
Sector: Healthcare
Employees: 57
Address: 1717 Main Street, Dallas, TX 75201
Phone: 254 244 5739
Last updated: 2024-11-08
Viking Therapeutics, Inc.
VK2809
Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing novel therapies for metabolic and endocrine disorders, with lead drug candidate VK2809 in Phase IIb trials for non-alcoholic steatohepatitis.
Symbol: VKTX
Recent Price: $39.77
Industry: Biotechnology
CEO: Dr. Brian Lian Ph.D.
Sector: Healthcare
Employees: 30
Address: 9920 Pacific Heights Boulevard, San Diego, CA 92121
Phone: 858 704 4660
Leadership
- Lawson Macartney, DVM, Ph.D., Chairman
- Matthew W. Foehr, Chief Executive Officer
- Kathy Rouan, Ph.D.,
- Charles A. Rowland Jr.,
- Matthew Singleton,
- Brian Lian, Ph.D.,
Last updated: 2024-12-31
VYNE Therapeutics Inc.
FCD105, FMX114, VYN201, VYN202
VYNE Therapeutics Inc. is a pharmaceutical company specializing in developing therapeutics for immuno-inflammatory conditions. Key products include FCD105 for acne vulgaris, FMX114 for atopic dermatitis, and BET inhibitors VYN201 and VYN202 for skin and other immuno-inflammatory diseases.
Symbol: VYNE
Recent Price: $3.19
Industry: Biotechnology
CEO: Mr. David T. Domzalski
Sector: Healthcare
Employees: 10
Address: 520 U.S. Highway 22, Bridgewater, NJ 08807
Phone: 800 775 7936
Last updated: 2024-12-31
Xilio Therapeutics, Inc.
XTX101
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients with a focus on tumor-selective therapies.
Symbol: XLO
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Rene Russo BCPS, Pharm.D.
Sector: Healthcare
Employees: 73
Address: 828 Winter Street, Waltham, MA 02451
Phone: 617 430 4680
Last updated: 2024-12-31
Theriva Biologics, Inc.
SYN-004, SYN-020, VCN-01
Theriva Biologics Inc. is a clinical-stage company developing therapeutics to address diseases with high unmet needs, including SYN-004 for preventing microbiome damage and SYN-020 for treating GI and systemic diseases.
Symbol: TOVX
Recent Price: $1.50
Industry: Biotechnology
CEO: Mr. Steven A. Shallcross CPA
Sector: Healthcare
Employees: 22
Address: 9605 Medical Center Drive, Rockville, MD 20850
Phone: 301 417 4364
Last updated: 2024-12-31
Immix Biopharma, Inc.
IMX-110, IMX-111, IMX-120
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.
Symbol: IMMX
Recent Price: $2.36
Industry: Biotechnology
CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Sector: Healthcare
Employees: 14
Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064
Phone: 310 651 8041
Last updated: 2024-12-31
Nuvectis Pharma, Inc.
NXP800, NXP900
Nuvectis Pharma, Inc., is a biopharmaceutical company that focuses on developing precision medicines for treating serious unmet medical needs in oncology. It is working on products like NXP800, a heat shock factor 1 pathway inhibitor, and NXP900, a drug candidate targeting Proto-oncogene c-Src and YES1 kinases.
Symbol: NVCT
Recent Price: $5.14
Industry: Biotechnology
CEO: Mr. Ron Bentsur M.B.A.
Sector: Healthcare
Employees: 13
Address: 1 Bridge Plaza, Fort Lee, NJ 07024
Phone: 201 614 3150
Last updated: 2024-12-31
Ventyx Biosciences, Inc.
VTX958
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing small molecule product candidates for the treatment of inflammatory diseases and autoimmune disorders. Key products include VTX958 for immune-mediated diseases, VTX002 for ulcerative colitis, and VTX2735 for systemic inflammatory diseases.
Symbol: VTYX
Recent Price: $2.23
Industry: Biotechnology
CEO: Dr. Raju S. Mohan Ph.D.
Sector: Healthcare
Employees: 73
Address: 662 Encinitas Boulevard, Encinitas, CA 92024
Phone: 760 593 4832
Last updated: 2024-12-31